Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-022765
Filing Date
2017-11-08
Accepted
2017-11-08 16:21:44
Documents
63
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rgnx-10q_20170930.htm 10-Q 2138813
2 EX-10.1 rgnx-ex101_168.htm EX-10.1 169174
3 EX-31.1 rgnx-ex311_9.htm EX-31.1 17081
4 EX-31.2 rgnx-ex312_7.htm EX-31.2 17052
5 EX-32.1 rgnx-ex321_8.htm EX-32.1 11304
6 GRAPHIC g201711081625528741056.jpg GRAPHIC 43956
  Complete submission text file 0001564590-17-022765.txt   7207754

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT rgnx-20170930.xml EX-101.INS 1553485
8 XBRL TAXONOMY EXTENSION SCHEMA rgnx-20170930.xsd EX-101.SCH 41853
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgnx-20170930_cal.xml EX-101.CAL 49190
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgnx-20170930_def.xml EX-101.DEF 155033
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgnx-20170930_lab.xml EX-101.LAB 349825
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgnx-20170930_pre.xml EX-101.PRE 271809
Mailing Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850
Business Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

EIN.: 471851754 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37553 | Film No.: 171186868
SIC: 2836 Biological Products, (No Diagnostic Substances)